This suggests that EGFR-blockade may to a larger extent inhibit both tumor growth and dissemination in sensitive models whereas the effects on tumor growth and dissemination seem to be uncoupled from each other in Paclitaxel treated models. This evidence concerns the gene EGFR and neoplasm.